CMIIT

SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease.

Focusing on the Future of Molecular Imaging

SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The primary focal areas of the Center are educational programs, professional and intersociety networking, and serving as a resource for development and implementation of SNMMI policy in this specialized area. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine. 

Vision:  

Molecular imaging and molecularly targeted therapy will be an integral part of the medical standard of care by providing specific information that will be used for diagnosis and to guide therapeutic decisions that improve health and well-being.

Mission:

To engage the molecular imaging community and leverage the SNMMI infrastructure to advance the adoption of emerging molecular imaging technologies and probes in preclinical and clinical applications.

Goals and Objectives

  • Ensure Nuclear Medicine Residency education contains sufficient MI content to make residents aware of and prepared for future molecular imaging clinical applications.
  • Develop educational resources for a “translational researcher”.  CMIIT will provide researchers with needed education and training on the “nuts and bolts” of translating and transitioning an agent or technique from pre-clinical research into the clinical practice (tracer development, equipment, funding).
  • Develop curriculum guidelines and resources for a molecular imaging scientist.
  • Public policies and regulations should facilitate the approval and adoption of new MI technologies.
  • Increase knowledge among members of the scientific community involved in biomedical research about the current value and future promise of molecular imaging, help cross fertilization to other disciplines, and make them aware of the power of molecular imaging and help researchers there get their advances and discoveries to clinic using in vivo imaging.
  • Diversify CMIIT’s membership.  CMIIT will represent a molecular imaging community that includes diversity in work role, modality and provide the appropriate resources for this diverse membership. 
  • Develop funding mechanisms for CMIIT projects.
  • Highlight and explore emerging technologies (such as nanoparticles) that may be novel, experimental, and possibly controversial.

CMIIT Sponsored Sessions at the SNMMI 2019 Annual Meeting

CAT 3: Molecular Imaging of Autoimmunity and Immune Checkpoint Inhibition Efficacy

CE02: Target Identification

CE23: Molecular Imaging in Drug Development

CE37: Cancer Immunotherapy: Current Status and Future Directions

CE51: US Regulatory Pathways for Diagnostic and Therapy Radiopharmaceuticals

CE86: AI for Data Sciences

 

2019 RPSC/CMIIT Poster Mixer

The RPSC and CMIIT would like to thank the 2019 Poster Mixer Sponsors: